Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$4.22 - $7.51 $84,691 - $150,718
20,069 New
20,069 $129,000
Q1 2022

May 16, 2022

SELL
$4.74 - $6.68 $73,507 - $103,593
-15,508 Closed
0 $0
Q4 2021

Mar 03, 2022

SELL
$6.15 - $7.68 $32,810 - $40,972
-5,335 Reduced 25.6%
15,508 $98,000
Q3 2021

Nov 15, 2021

BUY
$6.5 - $8.38 $6,916 - $8,916
1,064 Added 5.38%
20,843 $141,000
Q2 2021

Aug 16, 2021

BUY
$6.9 - $9.59 $16,187 - $22,498
2,346 Added 13.46%
19,779 $145,000
Q1 2021

May 17, 2021

BUY
$8.58 - $10.21 $21,733 - $25,861
2,533 Added 17.0%
17,433 $163,000
Q4 2020

Feb 16, 2021

BUY
$9.32 - $13.4 $138,868 - $199,660
14,900 New
14,900 $139,000

Others Institutions Holding LFVN

About Lifevantage Corp


  • Ticker LFVN
  • Exchange NASDAQ
  • Sector Consumer Defensive
  • Industry Packaged Foods
  • Shares Outstandng 12,560,000
  • Market Cap $318M
  • Description
  • LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically va...
More about LFVN
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.